migraine

by Elana Gotkine edited by Gaby Clark, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Fremanezumab yields a greater reduction in the number of migraine days and headache days than placebo among children and adolescents with episodic migraine, according to a study published in the Jan. 15 issue of the New England Journal of Medicine. Andrew

by Murdoch University edited by Sadie Harley, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Credit: Kindel Media from Pexels Two out of three adults diagnosed with complex regional pain syndrome (CRPS) will experience new or worsening migraines, with one in five patients suffering near-daily headaches. A new study from Murdoch University has established

by NYU Langone Health edited by Robert Egan  Editors’ notes Credit: Kindel Media from Pexels A smartphone app for muscle relaxation significantly reduced migraine-related disability in patients visiting the emergency department, a new study shows. Led by researchers from NYU Langone Health, the study featured a smartphone-based app that guides patients with migraine through progressive muscle relaxation (PMR), an evidence-based treatment

by Lori Solomon edited by Alexander Pol   The U.S. Food and Drug Administration has approved the single-dose Ajovy (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in children and adolescents. In the United States, one in 10 children and adolescents experience migraine, a common but often underrecognized and undertreated condition that can cause missed